ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,440 | +174041.3% | 478,000 | +282740.2% | 0.02% | – |
| Q1 2023 | $269 | – | 169 | +218.9% | 0.00% | – |
| Q3 2022 | $0 | – | 53 | +51.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 35 | -97.7% | 0.00% | – |
| Q4 2021 | $8,000 | +300.0% | 1,526 | +1111.1% | 0.00% | – |
| Q3 2021 | $2,000 | – | 126 | +6200.0% | 0.00% | – |
| Q2 2021 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 2 | -60.0% | 0.00% | – |
| Q4 2020 | $0 | – | 5 | -50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 10 | -99.9% | 0.00% | -100.0% |
| Q1 2020 | $558,000 | -47.2% | 17,710 | 0.0% | 0.04% | -43.0% |
| Q4 2019 | $1,056,000 | +273.1% | 17,710 | +129.7% | 0.08% | +229.2% |
| Q3 2019 | $283,000 | +253.8% | 7,710 | +285.5% | 0.02% | +166.7% |
| Q1 2019 | $80,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |